$28.37−0.1% on the day·+22.8% in a year·close Oct 13, 2026
Your signal
Buy72 / 100
Buy: 72 is at or above your Buy line of 60. Off the high (−2% from its 1-year high) scores 93 and lifts it; Plays in (58%) scores 58 and holds it back.
Every factor in this score has a tested record: each was checked month by month since 2011 on numbers public at the time.
Your signal is the one call Be The Puck makes on a stock, and you set it: weight the plays, analysts, P/E, growth, debt, trend and more, and move the Buy and Sell lines. Every page follows your choice. How the score works
All 18 factors for PFE
Factor
PFE
Points
What it is
Plays in
58%
58
The share of the plays you count that hold it now.
Analysts' upside
+3% · 26 analysts
33
How far analysts' average 12-month target sits above the price (3+ analysts). −20% scores 0, +50% full marks; at most 50 while the price is below its 200-day average, since targets lag a falling price.
Analysts' rating
2.5 · buy
27
The analysts' average recommendation: strong buy scores 100, hold or worse 0.
P/E
37.3×
30
Price over the last four quarters' earnings per share. Lower ranks higher; a loss scores 0. Source: SEC filings to 2026-06-28.
Forward P/E
9.8×
86
Price over next year's expected earnings. Lower ranks higher; an expected loss scores 0. Source: Yahoo Finance.
PEG
12.89
3
P/E divided by expected earnings growth. Lower ranks higher; around 1 is often read as fair for the growth. Source: Yahoo Finance.
Dividends over the last year as a share of the price. Higher ranks higher; no dividend scores 0. Source: SEC filings to 2026-06-28.
Earnings growth
−60%
9
Earnings per share over the last four quarters against the four before (the latest quarter on a year earlier where filings aren't available). Higher ranks higher. Source: SEC filings to 2026-06-28.
Revenue growth
−0%
10
Revenue over the last four quarters against the four before (the latest quarter on a year earlier where filings aren't available). Higher ranks higher. Source: SEC filings to 2026-06-28.
Debt against shareholders' equity. Lower ranks higher; negative equity scores 0. Source: SEC filings to 2026-06-28.
Off the high
−2% from its 1-year high
93
How far the price sits below its highest close of the last year: 100 points at the high, none at 30% or more below. The exit rule: a stock that keeps falling loses points whatever else it has going for it.
Trend
+9% vs 200-day
71
How far the price sits above its 200-day average. Higher ranks higher.
It closed 9% above its 200-day average and 2% below its 52-week high.
Crash exposure reads low: it operating profit covers interest only 3.8×.
Analysts' average 12-month target is $29.26, 3% above the close (26 analysts).
This analysis does not constitute trading advice. Please meet with an advisor or independently review sources before making any decision. New to this? Start with the basics.
Plays in58 / 100Every play Be The Puck tests, in 7 families.
A call is right when the stock rose after an in call or fell after an out call. Trend plays are built to take many small losses for a few big wins, so their hit rates run lower; being right often isn't the same as making the most money. How we test a play.
Each candle is one trading day: the box spans the open and close, the thin line the day's high and low. Hollow boxes closed up, filled boxes closed down. Toggle the averages to see the trend the plays read. Dots above the candles mark news and company filings: hover or tap one to see the story and how the stock moved from the last close before it, against the market on the same days.
What moved PFE lately
No session in the last 30 moved it twice a normal day against the S&P 500; these were its largest, the news read on each, and how reliably that kind of news has moved stocks before. How it's measured
Wed Oct 7+2.0% against the S&P 5001.5× a normal day
PFE +1.8%, the S&P 500 −0.2% that session; +3.3% against the S&P 500 over five sessions.
▲Price target raisedAnalyst rating · Oct 6, 4:08 pm ET
Scotiabank raised its price target to $33.00 from $30.00, keeping Sector Outperform.
After price target raises, stocks did better than their index at the first close after the news 55% of the time (2,637 of 4,768 on 215 stocks; median move +0.2%). Low predictability
PFE after price target raises: ahead of its index at the first close after the news 8 of 13 times (median +1.1%).
Mon Oct 5−2.1% against the S&P 5001.6× a normal day
PFE −1.4%, the S&P 500 +0.7% that session; +0.6% against the S&P 500 over five sessions.
After lawsuit and probe headlines, stocks did worse than their index at the first close after the news 58% of the time (14 of 24 on 17 stocks; median move −0.7%). Low predictabilityEarly read
Two years of calls, week by week
InOutShare of plays in
One row per play, grouped by family. When most rows turn green at once, the trend is broad. When they split, the plays disagree and the stock is usually chopping sideways.
Calls right: how often the play's calls on PFE went the right way since 2005. Record columns: play / buy and hold, annual return and worst drawdown since 2005. Click a column to sort.Sort with the menu above the list.
A crash marks every stock down; debt decides which companies come through. The storm test scores both halves: how hard the stock swings with the market, and how much debt it carries into a downturn. It describes fragility; it does not predict a crash.
Drug Manufacturers - General · Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite.
Size and valuation
Market cap
$162B
What the whole company is worth at today's price: share price × shares outstanding.
Revenue (last 12 months)
$63.7B
Total sales. The market values it at 2.5× sales.
P/E ratio
37.3×
Buyers pay $37 for each $1 of the last year's profit.
Forward P/E
9.8×
Price against analysts' estimate of next year's profit. Lower than the P/E means profit is expected to grow.
Price to book
1.9×
Price against the company's net assets (its equity) per share.
Profit and growth
Profit margin
6.8%
Keeps 7¢ of each dollar of sales as profit.
Revenue growth
−0.2%
The last four quarters' sales against the four before.
Earnings growth
−59.6%
Same comparison for profit.
Return on equity
5.1%
Yearly profit as a share of shareholders' money in the business.
Free cash flow
$12.5B
Cash left after running and investing in the business.
Loans and bonds it has to pay back, with interest.
Cash
$11.7B
Cash and short-term investments on hand.
Debt to equity
0.73×
Moderate.
Interest cover
3.8×
Operating profit divided by interest. Under 2× means one bad year could make the interest hard to pay.
Wall Street
Average analyst target
$29.26
3% above the close, from 26 analysts (range $25.00 to $36.00).
Consensus rating
Buy
Analysts' average recommendation. Ratings lean positive: sell ratings are rare.
Dividend yield
6.06%
Yearly dividends as a share of the price.
P/E, price to sales and book, growth, margin and return on equity from the company's SEC filings for the quarter to 2026-06-28; other company figures from Yahoo Finance, fetched Oct 14, 2026. Analyst targets are opinions, not forecasts Be The Puck checks.